Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by capebretongirlon Jul 02, 2021 5:57pm
192 Views
Post# 33488517

RE:RE:RE:The Re-opening will be swift...

RE:RE:RE:The Re-opening will be swift...I think its time for Tripp to update us on the status of Oncore - is it real today or a phantom of the past. Remember that in 2019 it did sign a $61 million dollar deal with Bodychek NL of the Netherlands, $40 million of which was earmarked for SZ over 5 years.  That would equate to a sizeable quarterly input to help out the revenue front.  References to Oncore by SZ are few and far between these days as covid capped marketing activities across the globe. If its real today, then update us - if its dead then just say so rather than raising hopes. The same goes for Coastal Medical which has become virtually lost in the shuffle - we have no idea if its contributing revenue, sales, marketing etc.  As shareholders we have the right and expectation to know what our partners are actually doing for us.  Nows the time for the updates. 


IainCaimbeul wrote: On the Oncore Pharma website if you select "buy tests" it shows colon, breast sentry and prostate index as coming soon - really eh! That should generate a lot of sales - sarc off.


<< Previous
Bullboard Posts
Next >>